Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

310417

Sigma-Aldrich

4-(Bromomethyl)phenylacetic acid

95%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
BrCH2C6H4CH2CO2H
CAS Number:
Molecular Weight:
229.07
Beilstein/REAXYS Number:
2360711
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

assay

95%

form

solid

mp

179-183 °C (lit.)

SMILES string

OC(=O)Cc1ccc(CBr)cc1

InChI

1S/C9H9BrO2/c10-6-8-3-1-7(2-4-8)5-9(11)12/h1-4H,5-6H2,(H,11,12)

InChI key

WCOCCXZFEJGHTC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

4-(Bromomethyl)phenylacetic acid was used as the precursor for serine protease inhibitor. It was also used in the synthesis of a novel crown ether receptor and 4-(acetoxymethyl)phenylacetic acid by reacting with excessive sodium acetate and acetic acid.

pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Zhiqiang Feng et al.
Bioorganic & medicinal chemistry letters, 19(8), 2270-2272 (2009-03-17)
We have developed a novel and moderately selective COX-2 inhibitor, imrecoxib, as a new anti-inflammatory drug. We describe herein the preparation of the major metabolites M2 and M4 of imrecoxib, as well as the in vitro and in vivo activities
R Rai et al.
Journal of medicinal chemistry, 35(23), 4297-4305 (1992-11-13)
Previously, we have reported that some guanidino-substituted alpha- and beta-aryl enol lactones I and II behaved as selective, mechanism-based inhibitors of some trypsin-like proteases (Rai, R.; Katzenellenbogen, J.A. J. Med. Chem., submitted). In this study, we describe the synthesis and
Journal of the Chemical Society. Chemical Communications, 399-399 (1993)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service